Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.87 is 49% below its 3-year average of 3.65, near the low end of its 3-year range (1.87–10.81).
As of the fiscal period ended Tuesday, June 30, 2026. 35.41% below its 12-month average of 2.90.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.87.
QUICK RATIO (ACID-TEST)
1.87
QUICK RATIO (ACID-TEST) AVG TTM
2.90
QUICK RATIO (ACID-TEST) AVG 3Y
3.65
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.41%
CURRENT VS 3Y AVG
-48.67%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-44.09%
vs the sector median at left
Tvardi Therapeutics, Inc.
Market Cap
$10.13M
Quick Ratio (Acid-Test)
1.87
TTM Avg
2.90
3Y Avg
3.65
5Y Avg
N/A
Market Cap
$10.06M
Quick Ratio (Acid-Test)
0.83
TTM Avg
3.08
3Y Avg
4.37
5Y Avg
4.67
Market Cap
$10.06M
Quick Ratio (Acid-Test)
1.57
TTM Avg
1.67
3Y Avg
1.44
5Y Avg
1.16
Market Cap
$9.86M
Quick Ratio (Acid-Test)
0.86
TTM Avg
14.33
3Y Avg
8.45
5Y Avg
7.70
Market Cap
$9.83M
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.19
3Y Avg
2.80
5Y Avg
3.17
Market Cap
$10.45M
Quick Ratio (Acid-Test)
5.63
TTM Avg
4.29
3Y Avg
4.04
5Y Avg
3.65
Market Cap
$9.71M
Quick Ratio (Acid-Test)
11.22
TTM Avg
10.96
3Y Avg
8.46
5Y Avg
6.93
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | $10.13M | 1.87 | 2.90 | 3.65 | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | 0.83 | 3.08 | 4.37 | 4.67 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 1.57 | 1.67 | 1.44 | 1.16 |
| Lifeward Ltd. (LFWD)vs › | $10.21M | 1.77 | 1.14 | 4.92 | 7.75 |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | 0.86 | 14.33 | 8.45 | 7.70 |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | 1.71 | 2.19 | 2.80 | 3.17 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | 5.63 | 4.29 | 4.04 | 3.65 |
| MetaVia Inc. (MTVA)vs › | $9.75M | 2.06 | 1.94 | 2.63 | 3.51 |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | 11.22 | 10.96 | 8.46 | 6.93 |
| Pluri Inc. (PLUR)vs › | $10.68M | 0.27 | 0.48 | 3.83 | 4.93 |
Quick Ratio
1.87
Excludes inventory
Current Ratio
1.87
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.87 |
| 2026-03-31 | 2.25 |
| 2025-12-31 | 2.86 |
| 2025-09-30 | 3.48 |
| 2025-06-30 | 4.04 |
| 2025-03-31 | 3.35 |
| 2024-12-31 | 10.81 |
| 2024-09-30 | 4.71 |
| 2024-06-30 | 4.48 |
| 2024-03-31 | 5.20 |
| 2023-12-31 | 7.97 |
| 2023-09-30 | 4.25 |
